Clinical Trial Update: Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating pregabalin for peripheral neuropathic pain has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathic Pain

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuropathic Pain | Phase 3 | Status: COMPLETED | Results posted: 2009-06-02